The Prototyping Grant 2018 is now open for applications!


BioFluidica is commercializing a diagnostic platform that provides a non-invasive procedure to diagnose many diseases where there is a need for improved diagnostics. The platform has been validated for six different cancer types, stroke, and infectious diseases. In the cancer field alone, there is a tremendous need to improve diagnostic capabilities.


Looking for: Strategic companies